Medicare Enrolled
Dr. Robert Waldrop, M.D.
Neurology · Johns Creek, GA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Waldrop from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Waldrop?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Waldrop
Dr. Robert Waldrop is a neurology specialist in Johns Creek, GA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Waldrop performed 980 Medicare services across 713 unique beneficiaries.
Between the years covered by Open Payments, Dr. Waldrop received a total of $18,897 from 77 pharmaceutical and/or device companies across 998 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Waldrop is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 29% volume in GA
$18,897 industry payments
Medicare Practice Summary
Medicare Utilization ↗980
Medicare services
Top 29% in GA for neurology
713
Unique beneficiaries
$94
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~52 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
265 | $98 | $387 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
204 | $78 | $290 |
| Limited needle EMG of arm or leg muscles A test that measures the electrical activity in specific muscles of the arm or leg using a needle electrode. This limited study evaluates muscle function in a targeted area. |
156 | $49 | $187 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
74 | $127 | $504 |
| Nerve conduction study, 9-10 studies A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function. |
62 | $164 | $624 |
| Nerve conduction studies, 7-8 tests A series of 7 to 8 nerve conduction tests to evaluate how well nerves are sending signals to muscles. |
56 | $121 | $468 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
41 | $62 | $274 |
| Psychological test administration, first 30 minutes A technician administers psychological or neuropsychological testing for the first 30 minutes. |
30 | $25 | $105 |
| Nerve conduction studies, 13 or more A diagnostic test that measures how well nerves send electrical signals. This code applies when 13 or more individual nerve studies are performed. |
28 | $226 | $844 |
| Limited ultrasound of joint or extremity A focused ultrasound exam of a specific joint or other structure in the arm or leg, excluding blood vessels. |
19 | $34 | $126 |
| Nerve conduction studies, 5-6 tests A series of 5 to 6 tests that measure how well nerves send electrical signals. The procedure evaluates nerve function and helps identify damage or dysfunction. |
19 | $108 | $376 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
14 | $143 | $540 |
| New patient office visit, complex (60-74 min) | 12 | $176 | $664 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$18,897
Total received (2018-2024)
Avg $2,700/year across 7 years
Top 17% in GA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
77
Companies
998
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$18,839 (99.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$58 (0.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,549
2023
$3,026
2022
$2,473
2021
$2,899
2020
$1,854
2019
$2,894
2018
$2,202
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$616
PFIZER INC.
$364
Novartis Pharmaceuticals Corporation
$210
Lundbeck LLC
$208
Eisai Inc.
$199
UCB, Inc.
$188
Lilly USA, LLC
$188
Biogen, Inc.
$161
Neurocrine Biosciences, Inc.
$159
ACADIA Pharmaceuticals Inc
$144
Celgene Corporation
$137
MDD US Operations, LLC
$129
ARGENX US, INC.
$96
Amneal Pharmaceuticals LLC
$86
Teva Pharmaceuticals USA, Inc.
$73
Takeda Pharmaceuticals U.S.A., Inc.
$72
Kyowa Kirin, Inc.
$68
Xeris Pharmaceuticals, Inc.
$60
Grifols USA, LLC
$47
Otsuka America Pharmaceutical, Inc.
$47
JAZZ PHARMACEUTICALS INC.
$45
Kedrion Biopharma, Inc.
$41
Genentech USA, Inc.
$41
Merz Pharmaceuticals, LLC
$40
SK Life Science, Inc.
$34
Saluda Medical Americas, Inc.
$28
Alnylam Pharmaceuticals Inc.
$26
Alexion Pharmaceuticals, Inc.
$24
Vanda Pharmaceuticals Inc.
$20
Top 3 companies account for 33.5% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$1,229
ABBVIE INC.
$892
AbbVie Inc.
$829
UCB, Inc.
$816
Biogen, Inc.
$762
Neurocrine Biosciences, Inc.
$736
Teva Pharmaceuticals USA, Inc.
$728
Amgen Inc.
$726
ACADIA Pharmaceuticals Inc
$670
PFIZER INC.
$544
Lundbeck LLC
$507
GENZYME CORPORATION
$494
Eisai Inc.
$474
Amneal Pharmaceuticals LLC
$462
Lilly USA, LLC
$454
Allergan Inc.
$399
Adamas Pharmaceuticals, Inc.
$393
Supernus Pharmaceuticals, Inc.
$386
UPSHER-SMITH LABORATORIES LLC
$377
Grifols USA, LLC
$373
CSL Behring
$370
Sunovion Pharmaceuticals Inc.
$353
Neurelis, Inc.
$319
SK Life Science, Inc.
$305
Avanir Pharmaceuticals, Inc.
$288
Upsher-Smith Laboratories LLC
$287
Kyowa Kirin, Inc.
$272
EMD Serono, Inc.
$270
Alexion Pharmaceuticals, Inc.
$268
Genentech USA, Inc.
$266
Allergan, Inc.
$263
GE HEALTHCARE
$261
MDD US Operations, LLC
$231
ARGENX US, INC.
$220
Otsuka America Pharmaceutical, Inc.
$187
Corium, LLC
$177
Celgene Corporation
$167
Promius Pharma LLC
$157
Acorda Therapeutics, Inc
$157
Biohaven Pharmaceutical Holding Company Ltd.
$153
Janssen Pharmaceuticals, Inc
$137
EISAI INC.
$120
Takeda Pharmaceuticals U.S.A., Inc.
$104
Impax Laboratories, Inc.
$98
IMPEL PHARMACEUTICALS INC.
$95
Avion Pharmaceuticals
$93
GE Healthcare
$75
JAZZ PHARMACEUTICALS INC.
$70
Currax Pharmaceuticals LLC
$68
Xeris Pharmaceuticals, Inc.
$60
BANNER LIFE SCIENCES, LLC
$60
US WorldMeds, LLC
$55
Boston Scientific Corporation
$53
Aprecia Pharmaceuticals, LLC
$44
Kedrion Biopharma, Inc.
$41
Merz Pharmaceuticals, LLC
$40
AbbVie, Inc.
$37
Mallinckrodt Hospital Products Inc.
$35
Abbott Laboratories
$29
Egalet US Inc
$28
Saluda Medical Americas, Inc.
$28
ARBOR PHARMACEUTICALS, INC.
$26
Alnylam Pharmaceuticals Inc.
$26
Merz North America, Inc.
$22
OWP Pharmaceuticals, Inc.
$22
Greenwich Biosciences, Inc.
$21
Mylan Pharmaceuticals Inc.
$21
MITSUBISHI TANABE PHARMA AMERICA, INC.
$21
Vanda Pharmaceuticals Inc.
$20
Bausch Health US, LLC
$19
Bayer HealthCare Pharmaceuticals Inc.
$17
Mallinckrodt LLC
$17
Mallinckrodt Enterprises LLC
$15
Biohaven Pharmaceuticals, Inc.
$15
SANOFI-AVENTIS U.S. LLC
$15
Merck Sharp & Dohme Corporation
$15
ASSERTIO THERAPEUTICS, Inc.
$14
Top 3 companies account for 15.6% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ADLARITY · ADUHELM · AIMOVIG · AJOVY · AMYVID · APOKYN · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Adlarity · Aimovig · Albuked · Austedo XR · BAFIERTAM · BELSOMRA · BOTOX · BOTOX THERAPEUTIC · Betaseron · Briviact · COMIRNATY · COPAXONE · CREXONT · DALVANCE · DUOPA · Dhivy · Duopa · EMGALITY · EPIDIOLEX · Epidiolex · Evoke · Fycompa · GAMMAGARD · GILENYA · GOCOVRI · Gamunex-C · General - Pain Management · Glatiramer Acetate · Gocovri · Gralise · HYQVIA · Hizentra · Horizant · INBRIJA · INFINITY · INGREZZA · KESIMPTA · KEVEYIS · KISUNLA · KYNMOBI · LEQEMBI · LYRICA · Lamotrigine Starter Kit · Leqembi · MAYZENT · MIGRANAL · Mavenclad · NEXVIAZYME · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Nourianz · Nuedexta · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONGENTYS · ONPATTRO · ONZETRA XSAIL · ONZETRA Xsail · Ocrevus · Ongentys · PANZYGA · PAXLOVID · POMPE - DISEASE · PONVORY · Ponvory · Privigen · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · RADICAVA · REXULTI · RYTARY · Rebif · Rystiggo · SOLIRIS · SPECTRA WAVEWRITER · SPINRAZA · SPRIX · SUNOSI · Soliris · Spritam · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · TYSABRI · Tosymra Sumatriptan Nasal Spray · Trudhesa · UBRELVY · ULTOMIRIS · Utibron · VALTOCO · VRAYLAR · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · XEOMIN · Xadago · Xeomin · ZEMBRACE SYMTOUCH · ZEPOSIA · Zembrace · Zembrace SymTouch Sumatriptan Injection
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Neurologists within 10 mi
228
Per 100K population
21.3
County median income
$91,490
Nearest hospital
EMORY JOHNS CREEK HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Waldrop is a clinical cardiology specialist, with above-average Medicare volume (top 29% in GA), with low-engagement industry engagement in the top 17% of GA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Waldrop experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Waldrop performed 265 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Waldrop receive payments from pharmaceutical companies?
Yes. Dr. Waldrop received a total of $18,897 from 77 companies across 998 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Waldrop's costs compare to other neurologists in Johns Creek?
Dr. Waldrop's average Medicare payment per service is $94. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Waldrop) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Johns Creek
Browse neurologists in Johns Creek ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in GA
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in GA
Which GA neurologists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
AbbVie Inc. Payments to Doctors
See all physicians who received payments from AbbVie Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology